BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2013
View Archived Issues
XL-protein presents novel PASylated biopharmaceuticals
Read More
A potential new protein biomarker of erectile dysfunction
Read More
Promising in vitro results for a novel gene therapy for mitochondrial diseases
Read More
Novel models developed for skin diseases and SLE
Read More
Novel TRVP1 ligands disclosed by Grunenthal
Read More
Intervet International prepares new DGAT1 inhibitors
Read More
French group divulges new cystathione beta-synthase inhibitors
Read More
MedImmune presents novel antibodies targeting P. aeruginosa
Read More
Alios BioPharma begins phase I trial of first-in-class nucleoside analogue targeting RSV
Read More
Achillion Pharmaceuticals chooses novel HCV drug candidate for clinical development
Read More
Inostics receives CLIA certification for blood-based mutation testing
Read More
VBL Therapeutics presents phase I/II results for VB-111
Read More
IND-enabling study of stem cell candidate for Parkinson's disease commences
Read More
GC-1008 is well tolerated but shows no clinical benefit in patients with glioma
Read More
Grant supports Epitarget's work to develop nanoparticulate immune stimulator
Read More
Vanda Pharmaceuticals submits NDA for tasimelteon
Read More
Omeros' OMS-824 shows binding to PDE10 in PET scans
Read More
Cancer Research UK launches phase I trial of AZD-3965
Read More
E Keppra approved in Japan for pediatric epilepsy
Read More
Filgrastim biosimilars launched in Japan
Read More
European CHMP recommends approval of pomalidomide for rrMM
Read More
Novo Nordisk seeks E.U. approval of IDegLira for type 2 diabetes
Read More
Depomed to cease investment in Sefelsa following receipt of complete response letter from FDA
Read More
Otsuka files application in Japan for tolvaptan in autosomal dominant polycystic kidney disease
Read More
European CHMP recommends approval of Lojuxta
Read More
CMDh endorses EMA committee's recommendation on benefit/risk profile of Diane-35
Read More
CHMP recommends European approval of once-weekly somatropin
Read More